Table 2 Neuroimaging findings of CSVD patients
|  | CSVD−D n = 34 | CSVD+D n = 36 | p-value |
|---|---|---|---|
Total CSVD Burden | |||
 CSVD score, median (IQR) | 1 (1) | 1.5 (1) | 0.415 |
 Grade 1, n (%) | 23 (67.6) | 18 (50.0) |  |
 Grade 2, n (%) | 8 (23.5) | 12 (33.3) |  |
 Grade 3, n (%) | 3 (8.8) | 5 (13.9) |  |
 Grade 4, n (%) | 0 (0) | 1 (2.8) |  |
Cerebrovascular lesions | |||
 WMH Fazekas 0–1, n (%) | 9 (26.5) | 4 (11.1) | 0.099 |
 WMH Fazekas 2–3, n (%) | 25 (73.5) | 32 (88.9) | |
 Lacunes occurrence, n (%) | 12 (35.3) | 18 (50.0) | 0.214 |
 CMBs occurrence, n (%) | 8 (23.5) | 9 (25.0) | 0.886 |
 EPVS occurrence, n (%) | 3 (8.8) | 2 (5.6) | 0.596 |
Neuroimaging measures | |||
 Total GMV, mean (SD) | 32.81 (2.33) | 32.74 (2.11) | 0.896 |
 Total WMV, mean (SD) | 26.94 (3.21) | 27.39 (2.56) | 0.435 |
 Total WMHV, mean (SD) | 3.14 (1.95) | 4.01 (2.27) | 0.091 |